Insider Transactions Reported by 18 Insiders of Sarepta Therapeutics, Inc.

Symbol
SRPT on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Sarepta Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard Barry Director $112,179,844 16 May 2025
Michael Andrew Chambers Director $29,507,710 18 Dec 2025
Douglas S. Ingram Chief Executive Officer, Director $16,729,038 07 Dec 2025
Dallan Murray Chief Customer Officer $5,881,591 07 Mar 2025
Bilal Arif Chief Tech Ops Officer $5,310,650 05 Aug 2025
M. Kathleen Behrens Director $4,593,375 27 Jan 2026
Louise Rodino-Klapac President, R&D and Tech Ops $4,168,475 11 Mar 2026
Ian Michael Estepan Chief Operating Officer $3,736,685 -$294,202 -7.3% 11 Mar 2026
Ryan Edward Brown EVP, General Counsel $2,818,063 21 Jun 2024
Cristin L. Rothfuss EVP, General Counsel $2,544,564 11 Mar 2026
Hans Lennart Rudolf Wigzell Director $2,525,579 10 Mar 2025
Ryan Ho-Yan Wong Chief Financial Officer $2,498,684 11 Mar 2026
William Ciambrone Evp $1,775,434 04 Mar 2022
Mary Ann Gray Director $992,681 07 Mar 2022
Kathryn Jean Boor Director $827,374 10 Mar 2025
Claude Nicaise Director $669,424 29 Jan 2026
Deirdre P. Connelly Director $523,179 10 Mar 2025
Stephen Mayo Director $30,040 -$123,208 -80% 12 Mar 2026

Recent Insider Transactions by Companies or Individuals for Sarepta Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Stephen Mayo SRPT Common Stock Sale -80.4% $123,208 $17.02 -7,239 1,765 12 Mar 2026 Direct
Ian Michael Estepan SRPT Common Stock Tax liability -0.54% -1,097 201,983 11 Mar 2026 Direct
Ryan Ho-Yan Wong SRPT Common Stock Tax liability -0.19% -256 135,064 11 Mar 2026 Direct
Louise Rodino-Klapac SRPT Common Stock Tax liability -0.42% -948 225,323 11 Mar 2026 Direct
Cristin L. Rothfuss SRPT Common Stock Tax liability -0.7% -974 137,544 11 Mar 2026 Direct
Ryan Ho-Yan Wong SRPT Common Stock Tax liability -0.2% -275 135,320 09 Mar 2026 Direct
Cristin L. Rothfuss SRPT Common Stock Tax liability -0.6% -830 138,518 09 Mar 2026 Direct
Louise Rodino-Klapac SRPT Common Stock Tax liability -0.61% -1,399 226,271 09 Mar 2026 Direct
Ian Michael Estepan SRPT Common Stock Tax liability -0.79% -1,619 203,080 09 Mar 2026 Direct
Cristin L. Rothfuss SRPT Common Stock Tax liability -0.29% -408 139,348 02 Mar 2026 Direct
Ryan Ho-Yan Wong SRPT Common Stock Tax liability -0.33% -450 135,595 02 Mar 2026 Direct
Ian Michael Estepan SRPT Common Stock Tax liability -2% -4,176 204,699 02 Mar 2026 Direct
Louise Rodino-Klapac SRPT Common Stock Tax liability -1.93% -4,485 227,670 02 Mar 2026 Direct
Ian Michael Estepan SRPT Common Stock Options Exercise 4.05% 8,125 208,875 01 Mar 2026 Direct
Ian Michael Estepan SRPT Performance Stock Units Options Exercise -100% -8,125 0 01 Mar 2026 Direct
Louise Rodino-Klapac SRPT Common Stock Options Exercise 3.63% 8,125 232,155 01 Mar 2026 Direct
Louise Rodino-Klapac SRPT Performance Stock Units Options Exercise -100% -8,125 0 01 Mar 2026 Direct
Ian Michael Estepan SRPT Common Stock Options Exercise 3.85% 7,450 200,750 26 Feb 2026 Direct
Ian Michael Estepan SRPT Stock Option (right to buy) Options Exercise -100% -7,450 0 26 Feb 2026 Direct
Ian Michael Estepan SRPT Performance Stock Units Award 30% 1,875 8,125 25 Feb 2026 Direct
Louise Rodino-Klapac SRPT Performance Stock Units Award 30% 1,875 8,125 25 Feb 2026 Direct
Claude Nicaise SRPT Common Stock Tax liability -17.7% -6,780 31,532 29 Jan 2026 Direct
Claude Nicaise SRPT Common Stock Options Exercise 37.8% 10,500 38,312 29 Jan 2026 Direct
Claude Nicaise SRPT Stock Option (right to buy) Options Exercise -100% -10,500 0 29 Jan 2026 Direct
M. Kathleen Behrens SRPT Common Stock Tax liability -3.18% -6,494 197,482 27 Jan 2026 Direct
M. Kathleen Behrens SRPT Common Stock Options Exercise 5.43% 10,500 203,976 27 Jan 2026 Direct
M. Kathleen Behrens SRPT Stock Option (right to buy) Options Exercise 10,500 0 27 Jan 2026 Direct
Michael Andrew Chambers SRPT Convertible Senior Notes Award 0 $20,000,000 18 Dec 2025 By Revocable Trust
Michael Andrew Chambers SRPT Convertible Senior Notes Disposed to Issuer 0 $0 18 Dec 2025 By Revocable Trust
Ian Michael Estepan SRPT Common Stock Sale -6.39% $294,202 $22.31 -13,187 193,300 16 Dec 2025 Direct
Douglas S. Ingram SRPT Common Stock Award 138.1% 539,084 929,391 07 Dec 2025 Direct
Ryan Ho-Yan Wong SRPT Common Stock Tax liability -0.12% -158 136,045 01 Dec 2025 Direct
Cristin L. Rothfuss SRPT Common Stock Tax liability -0.16% -229 139,756 28 Nov 2025 Direct
Louise Rodino-Klapac SRPT Common Stock Tax liability -2% -4,582 224,030 17 Nov 2025 Direct
Louise Rodino-Klapac SRPT Common Stock Award 169.8% 143,875 228,612 03 Sep 2025 Direct
Ryan Ho-Yan Wong SRPT Common Stock Award 686% 118,875 136,203 03 Sep 2025 Direct
Ian Michael Estepan SRPT Common Stock Award 229.8% 143,875 206,487 03 Sep 2025 Direct
Cristin Rothfuss SRPT Common Stock Award 563.1% 118,875 139,985 03 Sep 2025 Direct
Bilal Arif SRPT Performance Stock Units Award 6,250 6,250 05 Aug 2025 Direct
Ian Michael Estepan SRPT Performance Stock Units Award 6,250 6,250 05 Aug 2025 Direct
Louise Rodino-Klapac SRPT Performance Stock Units Award 6,250 6,250 05 Aug 2025 Direct
Ryan Ho-Yan Wong SRPT Common Stock Tax liability -1.85% -327 17,328 31 Jul 2025 Direct
Richard Barry SRPT Common Stock Options Exercise 0.42% 12,350 2,966,667 16 May 2025 Direct
Richard Barry SRPT Stock Option (right to buy) Options Exercise -100% -12,350 0 16 May 2025 Direct
Richard Barry SRPT Common Stock Options Exercise 0.69% 20,246 2,954,317 13 May 2025 Direct
Richard Barry SRPT Stock Option (right to buy) Options Exercise -100% -20,246 0 13 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.